Adial Pharmaceuticals, Inc.
(NASDAQ : ADIL)

( )
ADIL After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc.
-0.92%42.210.9%$1173.21m
JNJJohnson & Johnson
0.49%136.360.6%$1020.97m
MRKMerck & Co., Inc.
0.25%79.440.6%$955.62m
LLYEli Lilly and Company
0.45%122.681.0%$929.98m
BMYBristol-Myers Squibb Company
-0.12%51.301.4%$762.74m
ABBVAbbVie, Inc.
-0.66%79.992.2%$664.08m
AZNAstraZeneca PLC Sponsored ADR
0.20%40.541.3%$196.51m
NVSNovartis AG Sponsored ADR
0.89%90.770.2%$190.67m
GSKGlaxoSmithKline plc Sponsored ADR
0.17%41.360.2%$140.14m
NVONovo Nordisk A/S Sponsored ADR Class B
-1.24%49.700.1%$72.95m
SNYSanofi Sponsored ADR
-0.17%42.150.2%$37.62m
LCILannett Company, Inc.
2.57%9.8037.0%$16.93m
AKTXAkari Therapeutics Plc Sponsored ADR
-2.09%1.871.7%$0.06m
EPIXESSA Pharma Inc
2.67%3.810.1%$0.05m

Company Profile

ADial Pharmaceuticals LLC operates as a clinical stage biopharmaceutical company, which is focused on the treatment of alcohol use disorder. Its lead product AD04, a selective serotonin-3 antagonist is in Phase 3 clinical trial. The company was founded by Bankole A. Johnson in November 2010 and is headquartered in Charlottesville, VA.